Metropolitan Life Insurance CO Karyopharm Therapeutics Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

49 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.72 - $1.66 $4,486 - $10,343	6,231 New	6,231 $9,000
Q2 2023 Aug 10, 2023	BUY	$1.79 - $4.59 $3,529 - $9,051	1,972 Added 46.18%	6,242 $11,000
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $999 - $1,379	-352 Reduced 7.62%	4,270 $16,000
Q4 2022 Jun 14, 2023	BUY	$2.48 - $5.93 $872 - $2,087	352 Added 8.24%	4,622 $15.7 Million
Q3 2022 Jun 14, 2023	BUY	$4.08 - $5.82 $1,436 - $2,048	352 Added 8.24%	4,622 $25.2 Million
Q3 2022 Mar 30, 2023	BUY	$4.08 - $5.82 $8,013 - $11,430	1,964 Added 73.89%	4,622 $25,000
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $8,013 - $11,430	1,964 Added 73.89%	4,622 $25,000
Q2 2022 Jun 20, 2023	SELL	$4.15 - $8.37 $6,689 - $13,492	-1,612 Reduced 37.75%	2,658 $11,000
Q2 2022 Mar 30, 2023	SELL	$4.15 - $8.37 $8,939 - $18,028	-2,154 Reduced 44.76%	2,658 $11,000
Q2 2022 Aug 11, 2022	SELL	$4.15 - $8.37 $8,939 - $18,028	-2,154 Reduced 44.76%	2,658 $12,000
Q1 2022 Jun 20, 2023	BUY	$5.91 - $14.38 $3,203 - $7,793	542 Added 12.69%	4,812 $35,000
Q1 2022 Mar 30, 2023	SELL	$5.91 - $14.38 $48,272 - $117,455	-8,168 Reduced 62.93%	4,812 $35,000
Q1 2022 May 12, 2022	SELL	$5.91 - $14.38 $48,272 - $117,455	-8,168 Reduced 62.93%	4,812 $35,000
Q4 2021 Jun 21, 2023	BUY	$5.21 - $8.61 $45,379 - $74,993	8,710 Added 203.98%	12,980 $83,000
Q4 2021 Mar 30, 2023	BUY	$5.21 - $8.61 $7,528 - $12,441	1,445 Added 12.53%	12,980 $83,000
Q4 2021 Feb 15, 2022	BUY	$5.21 - $8.61 $7,528 - $12,441	1,445 Added 12.53%	12,980 $83,000
Q3 2021 Jun 21, 2023	BUY	$4.45 - $10.63 $32,329 - $77,226	7,265 Added 170.14%	11,535 $67,000
Q3 2021 Mar 30, 2023	SELL	$4.45 - $10.63 $47,668 - $113,868	-10,712 Reduced 48.15%	11,535 $67,000
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $47,668 - $113,868	-10,712 Reduced 48.15%	11,535 $67,000
Q2 2021 Jun 21, 2023	BUY	$8.11 - $11.11 $145,793 - $199,724	17,977 Added 421.01%	22,247 $229,000
Q2 2021 Mar 30, 2023	BUY	$8.11 - $11.11 $23,364 - $32,007	2,881 Added 14.88%	22,247 $229,000
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $180,269 - $246,953	22,228 Added 116989.47%	22,247 $230,000
Q1 2021 Jun 26, 2023	BUY	$9.85 - $17.69 $148,695 - $267,048	15,096 Added 353.54%	19,366 $204 Million
Q1 2021 Mar 30, 2023	SELL	$9.85 - $17.69 $23,383 - $41,996	-2,374 Reduced 10.92%	19,366 $203,000
Q1 2021 May 14, 2021	SELL	$9.85 - $17.69 $213,951 - $384,244	-21,721 Reduced 99.91%	19 $204,000
Q4 2020 Jun 22, 2023	BUY	$14.15 - $17.19 $247,200 - $300,309	17,470 Added 409.13%	21,740 $336,000
Q3 2020 Jun 26, 2023	BUY	$14.14 - $19.71 $247,025 - $344,333	17,470 Added 409.13%	21,740 $317,000
Q2 2020 Jun 26, 2023	BUY	$16.6 - $25.25 $290,002 - $441,117	17,470 Added 409.13%	21,740 $411,000
Q2 2020 Mar 30, 2023	BUY	$16.6 - $25.25 $57,768 - $87,870	3,480 Added 19.06%	21,740 $411,000
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $57,768 - $87,870	3,480 Added 19.06%	21,740 $412,000
Q1 2020 Jul 12, 2023	BUY	$14.38 - $27.72 $201,176 - $387,802	13,990 Added 327.63%	18,260 $350,000
Q1 2020 Mar 30, 2023	SELL	$14.38 - $27.72 $32,858 - $63,340	-2,285 Reduced 11.12%	18,260 $350,000
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $32,858 - $63,340	-2,285 Reduced 11.12%	18,260 $351,000
Q4 2019 Jul 12, 2023	BUY	$9.23 - $19.67 $150,218 - $320,129	16,275 Added 381.15%	20,545 $393,000
Q4 2019 Mar 30, 2023	SELL	$9.23 - $19.67 $7,134 - $15,204	-773 Reduced 3.63%	20,545 $393,000
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $7,134 - $15,204	-773 Reduced 3.63%	20,545 $394,000
Q3 2019 Jul 12, 2023	BUY	$5.66 - $11.85 $96,491 - $202,018	17,048 Added 399.25%	21,318 $205,000
Q3 2019 Mar 30, 2023	BUY	$5.66 - $11.85 $94,499 - $197,847	16,696 Added 361.23%	21,318 $205,000
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $120,659 - $252,618	21,318 New	21,318 $205,000
Q2 2019 Jul 12, 2023	BUY	$4.32 - $6.43 $1,637 - $2,436	379 Added 8.88%	4,649 $27.8 Million
Q1 2019 May 15, 2019	SELL	$4.12 - $10.25 $67,053 - $166,818	-16,275 Closed	0 $0
Q4 2018 Jul 13, 2023	BUY	$8.2 - $16.95 $98,440 - $203,484	12,005 Added 281.15%	16,275 $152,000
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $104,230 - $215,451	12,711 Added 356.65%	16,275 $152,000
Q3 2018 Jul 13, 2023	BUY	$17.03 - $21.18 $204,445 - $254,265	12,005 Added 281.15%	16,275 $277 Million
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $216,468 - $269,218	-12,711 Reduced 78.1%	3,564 $61,000
Q2 2018 Aug 15, 2018	BUY	$12.0 - $19.88 $54,672 - $90,573	4,556 Added 38.88%	16,275 $0
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $5,376 - $9,349	542 Added 4.85%	11,719 $0
Q4 2017 Feb 15, 2018	SELL	$9.15 - $11.99 $98,216 - $128,700	-10,734 Reduced 48.99%	11,177 $107,000
Q2 2017 Aug 14, 2017	BUY	N/A	21,911	21,911 $198,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account